BDBM476464 (2S)-1-[(2R)-2-[(1- methylethyl)amino]-2-{trans-4-[(1- methylethyl)amino]cyclohexyl}acetyl]- 4-[(4S,5S)-4-methyl-5-phenyl-4,5- dihydro-1,3-oxazol-2-yl]-N-(thiophen- 2-ylmethyl)piperazine-2-carboxamide::US10875851, Example 120

SMILES CC(C)N[C@H]([C@H]1CC[C@@H](CC1)NC(C)C)C(=O)N1CCN(C[C@H]1C(=O)NCc1cccs1)C1=N[C@@H](C)[C@@H](O1)c1ccccc1

InChI Key InChIKey=HGBCWGOUPAKLBU-QTGCLLNNSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 476464   

TargetCoagulation factor XII(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM476464((2S)-1-[(2R)-2-[(1- methylethyl)amino]-2-{trans-4-...)
Affinity DataIC50:  5.60nMAssay Description:The effectiveness of a compound of the present invention as an inhibitor of Coagulation Factor XIIa can be determined using a relevant purified serin...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent